title: A new approach to the prevention of graft-versus-host disease using XomaZyme-H65 following histo-incompatible partially T-depleted marrow grafts.
authors.affiliation: Department of Medicine, University of Kentucky Medical Center, Lexington 40536-0084.
authors.forename: P J
authors.initials: PJ
authors.lastname: Henslee
authors.forename: V S
authors.initials: VS
authors.lastname: Byers
authors.forename: C D
authors.initials: CD
authors.lastname: Jennings
authors.forename: E
authors.initials: E
authors.lastname: Marciniak
authors.forename: J S
authors.initials: JS
authors.lastname: Thompson
authors.forename: J S
authors.initials: JS
authors.lastname: Macdonald
authors.forename: E H
authors.initials: EH
authors.lastname: Romond
authors.forename: M J
authors.initials: MJ
authors.lastname: Messino
authors.forename: P J
authors.initials: PJ
authors.lastname: Scannon
mesh_terms: D000328:Adult; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D016026:Bone Marrow Transplantation / Q000276:immunology; D004341:Drug Evaluation; D006086:Graft vs Host Disease / Q000276:immunology / Q000517:prevention & control*; D006650:Histocompatibility Testing; D006801:Humans; D000922:Immunotoxins / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000276:immunology / Q000601:surgery / Q000628:therapy; D008212:Lymphocyte Depletion; D008297:Male; D011183:Postoperative Complications / Q000517:prevention & control; D012276:Ricin / Q000276:immunology / Q000627:therapeutic use*; D013601:T-Lymphocytes
chemical_list: D000911:Antibodies, Monoclonal; D000922:Immunotoxins; C068230:zolimomab aritox; D012276:Ricin